TY - JOUR
T1 - Interstitial laser coagulation (ILC) for benign prostatic hyperplasia
T2 - Our experience after 12 months
AU - Formiconi, A.
AU - Ferrando, U.
AU - Tasso, M.
AU - Mengozzi, G.
AU - Fop, F.
AU - Moretti, F.
AU - Montorsi, F.
PY - 1999
Y1 - 1999
N2 - Interstitial laser induced coagulation (ILC) is a minimally invasive procedure for benign prostatic hyperplasia (BPH) which was first used by Muschter and Hoffstetter (3, 4). Prostate tissue is coagulated by means of diffused laser light, using a diode laser system with a temperature feedback (Indigo Medical 830c TM). In BPH, ILC aims at a reduction in volume, a decrease in outlet obstruction and improvement in lower urinary tract symptoms with low morbidity. We report our preliminary experience in treating 38 patients with BPH and BOO (bladder outlet obstruction) from May '98 to June '99 after a mean follow-up of 6 months. Inclusion criteria were: 1) age over 40 years, 2) maximum flow rate <12 ml/s., 3) AUA symptom score > 12, sterile urine culture, 5) PSA <4 ng/ml. All patients were catheterized for 10 days after treatment. The AUA score, maximum flow rate, Quality of Life (QL) index, post-voiding residual volume, prostate and urethra size (determined by ultrasound) were all significantly improved at 1, 3, 6 and 12 months (p
AB - Interstitial laser induced coagulation (ILC) is a minimally invasive procedure for benign prostatic hyperplasia (BPH) which was first used by Muschter and Hoffstetter (3, 4). Prostate tissue is coagulated by means of diffused laser light, using a diode laser system with a temperature feedback (Indigo Medical 830c TM). In BPH, ILC aims at a reduction in volume, a decrease in outlet obstruction and improvement in lower urinary tract symptoms with low morbidity. We report our preliminary experience in treating 38 patients with BPH and BOO (bladder outlet obstruction) from May '98 to June '99 after a mean follow-up of 6 months. Inclusion criteria were: 1) age over 40 years, 2) maximum flow rate <12 ml/s., 3) AUA symptom score > 12, sterile urine culture, 5) PSA <4 ng/ml. All patients were catheterized for 10 days after treatment. The AUA score, maximum flow rate, Quality of Life (QL) index, post-voiding residual volume, prostate and urethra size (determined by ultrasound) were all significantly improved at 1, 3, 6 and 12 months (p
KW - Benign prostatic hyperplasia
KW - ILC
KW - Laser
KW - Obstruction
UR - http://www.scopus.com/inward/record.url?scp=0033498908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033498908&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0033498908
VL - 13
SP - 221
EP - 226
JO - Acta Urologica Italica
JF - Acta Urologica Italica
SN - 0394-2511
IS - 5-6
ER -